These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
399 related items for PubMed ID: 20885442
1. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Puisségur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K, Maurin T, Lebrigand K, Cardinaud B, Hofman V, Fourre S, Magnone V, Ricci JE, Pouysségur J, Gounon P, Hofman P, Barbry P, Mari B. Cell Death Differ; 2011 Mar; 18(3):465-78. PubMed ID: 20885442 [Abstract] [Full Text] [Related]
3. MiR-200c downregulates HIF-1α and inhibits migration of lung cancer cells. Byun Y, Choi YC, Jeong Y, Lee G, Yoon S, Jeong Y, Yoon J, Baek K. Cell Mol Biol Lett; 2019 Mar; 24():28. PubMed ID: 31061665 [Abstract] [Full Text] [Related]
4. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS. Takkar S, Sharma V, Ghosh S, Suri A, Sarkar C, Kulshreshtha R. Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841 [Abstract] [Full Text] [Related]
5. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells. Iacona JR, Monteleone NJ, Lemenze AD, Cornett AL, Lutz CS. RNA Biol; 2019 Dec; 16(12):1721-1732. PubMed ID: 31425002 [Abstract] [Full Text] [Related]
6. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Cui R, Kim T, Fassan M, Meng W, Sun HL, Jeon YJ, Vicentini C, Tili E, Peng Y, Scarpa A, Liang G, Zhang YK, Chakravarti A, Croce CM. Oncotarget; 2015 Sep 08; 6(26):21802-15. PubMed ID: 26307684 [Abstract] [Full Text] [Related]
11. MiR-183-5p inhibits lung squamous cell carcinoma survival through disrupting hypoxia adaptation mediated by HIF-1α/NDUFA4L2 axis. Han P, Zhang B, Li Y, Gao R, Li X, Ren H, Shi P, Zhao A, Xue J, Yang A, Liang Y. Oncogene; 2024 Sep 08; 43(38):2821-2834. PubMed ID: 39154121 [Abstract] [Full Text] [Related]
12. Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation. Yang JX, Chuang YC, Tseng JC, Liu YL, Lai CY, Lee AY, Huang CF, Hong YR, Chuang TH. J Exp Clin Cancer Res; 2024 Jun 17; 43(1):169. PubMed ID: 38880883 [Abstract] [Full Text] [Related]
14. Circular RNA circPIP5K1A promotes non-small cell lung cancer proliferation and metastasis through miR-600/HIF-1α regulation. Chi Y, Luo Q, Song Y, Yang F, Wang Y, Jin M, Zhang D. J Cell Biochem; 2019 Nov 17; 120(11):19019-19030. PubMed ID: 31241217 [Abstract] [Full Text] [Related]
15. Upregulated miR-17 Regulates Hypoxia-Mediated Human Pulmonary Artery Smooth Muscle Cell Proliferation and Apoptosis by Targeting Mitofusin 2. Lu Z, Li S, Zhao S, Fa X. Med Sci Monit; 2016 Sep 18; 22():3301-8. PubMed ID: 27640178 [Abstract] [Full Text] [Related]
16. MiR-15a expression analysis in non-small cell lung cancer A549 cells under local hypoxia microenvironment. Jing XG, Chen TF, Huang C, Wang H, An L, Cheng Z, Zhang GJ. Eur Rev Med Pharmacol Sci; 2017 May 18; 21(9):2069-2074. PubMed ID: 28537679 [Abstract] [Full Text] [Related]
20. MicroRNA-130a targeting hypoxia-inducible factor 1 alpha suppresses cell metastasis and Warburg effect of NSCLC cells under hypoxia. Shi J, Wang H, Feng W, Huang S, An J, Qiu Y, Wu K. Life Sci; 2020 Aug 15; 255():117826. PubMed ID: 32450163 [Abstract] [Full Text] [Related] Page: [Next] [New Search]